Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
SABCS 2024: Highlights in breast cancer genomic testing
SABCS 2024: Highlights in breast cancer genomic testing
Prof Matteo Lambertini and Prof Virginia Kaklamani
Data from the CLARITY trial of ibrutinib plus venetoclax
Prof Peter Hillmen - University of Leeds, Leeds, UK
Data from the CLARITY trial of ibrutinib plus venetoclax ( Prof Peter Hillmen - University of Leeds, Leeds, UK )
10 Dec 2017
Mogamulizumab for cutaneous T- cell lymphoma
Prof Youn Kim - Stanford University, Stanford, CA
Mogamulizumab for cutaneous T- cell lymphoma ( Prof Youn Kim - Stanford University, Stanford, CA )
10 Dec 2017
Phase 1 study of Blu-285 in advanced systemic mastocytosis
Prof Daniel DeAngelo - Dana-Farber Cancer Institute, Boston, USA
Phase 1 study of Blu-285 in advanced systemic mastocytosis ( Prof Daniel DeAngelo - Dana-Farber Cancer Institute, Boston, USA )
10 Dec 2017
Ibrutinib plus venetoclax for previously treated CLL: CLARITY trial
Prof Peter Hillmen - University of Leeds, Leeds, UK
Ibrutinib plus venetoclax for previously treated CLL: CLARITY trial ( Prof Peter Hillmen - University of Leeds, Leeds, UK )
10 Dec 2017
Data from the JULIET trial of CTL019 for relapsed or refractory diffuse large B...
Dr Stephen Schuster - University of Pennsylvania, Philadelphia, USA
Data from the JULIET trial of CTL019 for relapsed or refractory diffuse large B-cell lymphoma ( Dr Stephen Schuster - University of Pennsylvania, Philadelphia, USA )
10 Dec 2017
Brentuximab vedotin for advanced Hodgkin lymphoma in the ECHELON-1 study
Dr Joseph Connors - British Columbia Cancer Agency, Vancouver, Canada
Brentuximab vedotin for advanced Hodgkin lymphoma in the ECHELON-1 study ( Dr Joseph Connors - British Columbia Cancer Agency, Vancouver, Canada )
10 Dec 2017
New treatments for acute myeloid leukaemia
Dr Anna Halpern - Seattle Cancer Care Alliance, Seattle, USA
New treatments for acute myeloid leukaemia ( Dr Anna Halpern - Seattle Cancer Care Alliance, Seattle, USA )
10 Dec 2017
ECHELON-1 study of brentuximab vedotin as frontline therapy for Hodgkin's...
Dr Joseph Connors - British Columbia Cancer Agency, Vancouver, Canada
ECHELON-1 study of brentuximab vedotin as frontline therapy for Hodgkin's lymphoma ( Dr Joseph Connors - British Columbia Cancer Agency, Vancouver, Canada )
10 Dec 2017
Long term follow up on the ZUMA-1 trial for nHL
Dr Sattva Neelapu - MD Anderson Center, Houston, USA
Long term follow up on the ZUMA-1 trial for nHL ( Dr Sattva Neelapu - MD Anderson Center, Houston, USA )
10 Dec 2017
BLU-285 for advanced systemic mastocytosis
Prof Daniel DeAngelo - Dana-Farber Cancer Institute, Boston, USA
BLU-285 for advanced systemic mastocytosis ( Prof Daniel DeAngelo - Dana-Farber Cancer Institute, Boston, USA )
10 Dec 2017
Mogamulizumab demonstrates significant improvement in progression free survival...
Dr Steven Horwitz - Memorial Sloan Kettering Cancer Center, New York, USA
Mogamulizumab demonstrates significant improvement in progression free survival for CTCL ( Dr Steven Horwitz - Memorial Sloan Kettering Cancer Center, New York, USA )
10 Dec 2017
SABCS 2017: The latest in CDK inhibition in breast cancer
Prof Nadia Harbeck, Dr Mark Beresford, Dr Shom Goel and Dr Sara Hurvitz
SABCS 2017: The latest in CDK inhibition in breast cancer ( Prof Nadia Harbeck, Dr Mark Beresford, Dr Shom Goel and Dr Sara Hurvitz )
10 Dec 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation